Vaccin pfizer biontech - activities

Covid: three Omicron-specific vaccines approved by the French Health Authority

As an umpteenth Covid wave threatens France this Fall, the French Health Authority (HAS) announced this Tuesday September 20, 2022, they approved the issuance in France of three Omicron-specific vaccines to effectively fight against the virus and transmission. “Bivalent” vaccines developed by Pfizer/BioNTech and Moderna, all three approved earlier by the European Medicines Agency.

Covid: Pfizer to vaccinate children under 5 in 2022

After 5-11 years old, drugmaker Pfizer now wishes to vaccinate children under 5 years of age. They announced tests have already begun and they will seek approval by mid-2022.

Covid - Omicron variant: Pfizer vaccine 70% effective against severe disease, a study found

According toa South-African study carried out by the South African Medical Research Council, the Pfizer vaccine is 70% effective against the Covid Omicron variant, although it is still more resistant, according to a study carried out by the Africa Health Research Institute from Durban. Keep reading to find out more!

Covid: third dose of Pfizer 95.6% effective against the virus, the laboratory claims

Pfizer-BioNTech has carried out a study showing their booster shot is 95.6% effective against symptomatic Covid-19.

Covid: vaccine coming as an intranasal spray, pill or powder… More on the ongoing researches

As Covid vaccine campaigns go on across the world, searchers keep working on new ways to give the vaccine. Spray, pill, powder… Keep reading to find out more about the ongoing researches!

Covid: the government speaks about two billion euros to buy vaccines in 2022

The French government plans to spend two billion euros to vaccinate against Covid-19 in 2022. But how will all these doses be useful?

Covid – Delta variant: a study finds the Pfizer vaccine is less effective in the long-run than AstraZeneca

The Pfizer vaccine is less effective in the long-run against the Covid Delta variant than AstraZeneca… This is the conclusion reached by a study issued this Thursday August 19, 2021 carried out by scientists from the Oxford University. But both vaccines are yet “highly” effective.

Covid: when faced with the Delta variant, Moderna vaccine more effective than Pfizer, according to a study

According to a preliminary US study, the Moderna vaccine is far more effective against the Delta variant of Covid-19 than the Pfizer vaccine.

Covid: mixing mRNA and viral vector vaccines likely to reinforce immunity, a study found

Receiving two doses of vaccines with different technologies (mRNA and viral vector) is likely to increase immunity against Covid, a study released this past July 26 in Nature magazine found. Keep reading to find out more!

Covid vaccines: side effects reported and listed in France

Vaccination goes on in France and the health authorities are thoroughly monitoring the different vaccines available. Here is the list of side effects reported in France.

Covid – Delta variant: a “new vaccine within 100 days”, BioNTech claims

Both German laboratory BioNTech founders stated in an interview with our peers from Les Echos they are able to supply a new Covid vaccine, adapted to the Delta variant, within 100 days. An achievment reached thanks to the mRNA technology.

Covid: can you get another vaccine for the 2nd shot?

Is it possible to get another vaccine for the 2nd shot? Medical interest, governmental authorization, here is more about this "mix and match" option likely to enable us to change vaccine during the process... or not.

Covid: Pfizer vaccine effective against the Indian variant, Institut Pasteur found

Good news in the race for Covid vaccines! According to several studies led in the United Kingdom, the Pfizer and AstraZeneca vaccines seem to be working against the Indian variant, at 88% for the former and 60% for the latter after the second injection. Results quite similar to those from the two vaccines against the UK variant. A study carried out by the Institut Pasteur issued this May 28 confirms Pfizer's effectiveness against the Indian variant.

Covid: vaccinating 12-15 y.o. with Pfizer allowed in Europe

Following consultation, this Friday May 28, the European Medicines Agency has approved vaccinating teenagers from 12 years old with Pfizer. As for France, the country is still waiting for the report from the Haute Autorité de Santé likely to be handed over "next week".

Covid: EMA allows stocking Pfizer vaccine in standard refrigerators

This Friday March 26, the European Medicines Agency announced Pfizer/BioNTech Covid vaccine can be stored at higher temperatures than recommended so far, for two weeks, making storage easier. An authorization following recommendations issued in mid-February by the American laboratory in terms of storage.

Covid vaccine: answers to questions you may have

As Covid vaccination is growing in France, many of you are wondering about the vaccines and how such an action is useful to curb the spread of the virus. Questions the editorial board tries to answer to.

Covid vaccine: BioNTech makes a deal with the EU for an extra 100 million doses

A new deal has been made between laboratory BioNTech and the European Union enabling Europe to get 100 million extra coronavirus vaccine doses. This year’s order reaches 600 million doses of the Pfizer/BioNTech vaccine which is expected to make it possible to vaccinate two thirds of the EU population.

Covid: vaccine doses to be anonymized in France?

As more and more French distrust some Covid vaccines, Europe 1 radio station reports the Health Minister is considering anonymizing doses and therefore no longer tell the name of the vaccine given to the person during the appointment.

Covid: the time period between Pfizer and Moderna vaccine doses will be extended to 42 days

Olivier Véran announced in an interview with Journal du Dimanche that the time period between the two doses of vaccine will be extended to 42 days for patients given the Pfizer or Moderna vaccine.

Pfizer: France has launched the vaccine production in the country

According to news from our peers from Journal du Dimanche, the manufacturing of the Pfizer/BioNTech vaccine is to begin in France, at Delpharm, an expert in packing pharmaceutical product, starting Wednesday April 7. This is the very first Covid vaccine produced in France. In all 250 million doses are to be issued by the end of the year, according to Industry Minister Agnès Pannier-Runacher.